Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Jun;70(824):393–403. doi: 10.1136/pgmj.70.824.393

Recent advances in the neurology of HIV infection.

R K Petty 1
PMCID: PMC2397728  PMID: 8029159

Full text

PDF
393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Achim C. L., Schrier R. D., Wiley C. A. Immunopathogenesis of HIV encephalitis. Brain Pathol. 1991 Apr;1(3):177–184. doi: 10.1111/j.1750-3639.1991.tb00657.x. [DOI] [PubMed] [Google Scholar]
  2. Apostolski S., McAlarney T., Quattrini A., Levison S. W., Rosoklija G., Lugaressi A., Corbo M., Sadiq S. A., Lederman S., Hays A. P. The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol. 1993 Dec;34(6):855–863. doi: 10.1002/ana.410340616. [DOI] [PubMed] [Google Scholar]
  3. Appleman M. E., Marshall D. W., Brey R. L., Houk R. W., Beatty D. C., Winn R. E., Melcher G. P., Wise M. G., Sumaya C. V., Boswell R. N. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunodeficiency virus. J Infect Dis. 1988 Jul;158(1):193–199. doi: 10.1093/infdis/158.1.193. [DOI] [PubMed] [Google Scholar]
  4. BRAIN The neurological complications of neoplasms. Lancet. 1963 Jan 26;1(7274):179–184. doi: 10.1016/s0140-6736(63)91207-8. [DOI] [PubMed] [Google Scholar]
  5. Baumgartner J. E., Rachlin J. R., Beckstead J. H., Meeker T. C., Levy R. M., Wara W. M., Rosenblum M. L. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg. 1990 Aug;73(2):206–211. doi: 10.3171/jns.1990.73.2.0206. [DOI] [PubMed] [Google Scholar]
  6. Berenguer J., Moreno S., Laguna F., Vicente T., Adrados M., Ortega A., González-LaHoz J., Bouza E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 1992 Mar 5;326(10):668–672. doi: 10.1056/NEJM199203053261004. [DOI] [PubMed] [Google Scholar]
  7. Berger J. R. Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study. Arch Neurol. 1991 Jul;48(7):700–702. doi: 10.1001/archneur.1991.00530190046014. [DOI] [PubMed] [Google Scholar]
  8. Berger J. R., Tornatore C., Major E. O., Bruce J., Shapshak P., Yoshioka M., Houff S., Sheremata W., Horton G. F., Landy H. Relapsing and remitting human immunodeficiency virus-associated leukoencephalomyelopathy. Ann Neurol. 1992 Jan;31(1):34–38. doi: 10.1002/ana.410310107. [DOI] [PubMed] [Google Scholar]
  9. Berger J. R., Waskin H., Pall L., Hensley G., Ihmedian I., Post M. J. Syphilitic cerebral gumma with HIV infection. Neurology. 1992 Jul;42(7):1282–1287. doi: 10.1212/wnl.42.7.1282. [DOI] [PubMed] [Google Scholar]
  10. Bornstein R. A., Nasrallah H. A., Para M. F., Whitacre C. C., Rosenberger P., Fass R. J. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS. 1993 Apr;7(4):519–524. doi: 10.1097/00002030-199304000-00011. [DOI] [PubMed] [Google Scholar]
  11. Bozzette S. A., Larsen R. A., Chiu J., Leal M. A., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J. A., Tilles J. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1991 Feb 28;324(9):580–584. doi: 10.1056/NEJM199102283240902. [DOI] [PubMed] [Google Scholar]
  12. Britton C. B., Mesa-Tejada R., Fenoglio C. M., Hays A. P., Garvey G. G., Miller J. R. A new complication of AIDS: thoracic myelitis caused by herpes simplex virus. Neurology. 1985 Jul;35(7):1071–1074. doi: 10.1212/wnl.35.7.1071. [DOI] [PubMed] [Google Scholar]
  13. Bronnimann D. A., Adam R. D., Galgiani J. N., Habib M. P., Petersen E. A., Porter B., Bloom J. W. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Mar;106(3):372–379. doi: 10.7326/0003-4819-106-3-372. [DOI] [PubMed] [Google Scholar]
  14. Budka H. Neuropathology of human immunodeficiency virus infection. Brain Pathol. 1991 Apr;1(3):163–175. doi: 10.1111/j.1750-3639.1991.tb00656.x. [DOI] [PubMed] [Google Scholar]
  15. Budka H., Wiley C. A., Kleihues P., Artigas J., Asbury A. K., Cho E. S., Cornblath D. R., Dal Canto M. C., DeGirolami U., Dickson D. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991 Apr;1(3):143–152. doi: 10.1111/j.1750-3639.1991.tb00653.x. [DOI] [PubMed] [Google Scholar]
  16. Burgess A., Riccio M. Cognitive impairment and dementia in HIV-1 infection. Baillieres Clin Neurol. 1992 Apr;1(1):155–174. [PubMed] [Google Scholar]
  17. Carne C. A., Tedder R. S., Smith A., Sutherland S., Elkington S. G., Daly H. M., Preston F. E., Craske J. Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet. 1985 Nov 30;2(8466):1206–1208. doi: 10.1016/s0140-6736(85)90740-8. [DOI] [PubMed] [Google Scholar]
  18. Casabona J., Sánchez E., Graus F., Abós J., Segura A. Trends and survival for AIDS patients presenting with indicative neurologic diseases. Acta Neurol Scand. 1991 Jul;84(1):51–55. doi: 10.1111/j.1600-0404.1991.tb04902.x. [DOI] [PubMed] [Google Scholar]
  19. Chalmers A. C., Greco C. M., Miller R. G. Prognosis in AZT myopathy. Neurology. 1991 Aug;41(8):1181–1184. doi: 10.1212/wnl.41.8.1181. [DOI] [PubMed] [Google Scholar]
  20. Chuck S. L., Sande M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 21;321(12):794–799. doi: 10.1056/NEJM198909213211205. [DOI] [PubMed] [Google Scholar]
  21. Cinque P., Brytting M., Vago L., Castagna A., Parravicini C., Zanchetta N., D'Arminio Monforte A., Wahren B., Lazzarin A., Linde A. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet. 1993 Aug 14;342(8868):398–401. doi: 10.1016/0140-6736(93)92814-a. [DOI] [PubMed] [Google Scholar]
  22. Coker R. J., Viviani M., Gazzard B. G., Du Pont B., Pohle H. D., Murphy S. M., Atouguia J., Champalimaud J. L., Harris J. R. Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS. 1993 Jun;7(6):829–835. doi: 10.1097/00002030-199306000-00011. [DOI] [PubMed] [Google Scholar]
  23. Connolly S., Manji H., McAllister R. H., Fell M., Loveday C., Kirkis C., Herns M., Sweeney B., Sartawi O., Durrance P. Long-latency event-related potentials in asymptomatic human immunodeficiency virus type 1 infection. Ann Neurol. 1994 Feb;35(2):189–196. doi: 10.1002/ana.410350210. [DOI] [PubMed] [Google Scholar]
  24. Cornblath D. R., McArthur J. C., Kennedy P. G., Witte A. S., Griffin J. W. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol. 1987 Jan;21(1):32–40. doi: 10.1002/ana.410210107. [DOI] [PubMed] [Google Scholar]
  25. Daar E. S., Moudgil T., Meyer R. D., Ho D. D. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med. 1991 Apr 4;324(14):961–964. doi: 10.1056/NEJM199104043241405. [DOI] [PubMed] [Google Scholar]
  26. Dalakas M. C., Illa I., Pezeshkpour G. H., Laukaitis J. P., Cohen B., Griffin J. L. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990 Apr 19;322(16):1098–1105. doi: 10.1056/NEJM199004193221602. [DOI] [PubMed] [Google Scholar]
  27. Dalakas M. C., Pezeshkpour G. H. Neuromuscular diseases associated with human immunodeficiency virus infection. Ann Neurol. 1988;23 (Suppl):S38–S48. doi: 10.1002/ana.410230713. [DOI] [PubMed] [Google Scholar]
  28. Davis L. E., Hjelle B. L., Miller V. E., Palmer D. L., Llewellyn A. L., Merlin T. L., Young S. A., Mills R. G., Wachsman W., Wiley C. A. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology. 1992 Sep;42(9):1736–1739. doi: 10.1212/wnl.42.9.1736. [DOI] [PubMed] [Google Scholar]
  29. Denning D. W., Anderson J., Rudge P., Smith H. Acute myelopathy associated with primary infection with human immunodeficiency virus. Br Med J (Clin Res Ed) 1987 Jan 17;294(6565):143–144. doi: 10.1136/bmj.294.6565.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Dooneief G., Bello J., Todak G., Mun I. K., Marder K., Malouf R., Gorman J., Hilal S., Stern Y., Mayeux R. A prospective controlled study of magnetic resonance imaging of the brain in gay men and parenteral drug users with human immunodeficiency virus infection. Arch Neurol. 1992 Jan;49(1):38–43. doi: 10.1001/archneur.1992.00530250042014. [DOI] [PubMed] [Google Scholar]
  31. Dubinsky R. M., Yarchoan R., Dalakas M., Broder S. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC). Muscle Nerve. 1989 Oct;12(10):856–860. doi: 10.1002/mus.880121012. [DOI] [PubMed] [Google Scholar]
  32. Dubois-Dalcq M. E., Jordan C. A., Kelly W. B., Watkins B. A. Understanding HIV-1 infection of the brain: a challenge for neurobiologists. AIDS. 1990;4 (Suppl 1):S67–S76. [PubMed] [Google Scholar]
  33. Dunlop O., Bjørklund R. A., Abdelnoor M., Myrvang B. Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand. 1992 Sep;86(3):260–266. doi: 10.1111/j.1600-0404.1992.tb05082.x. [DOI] [PubMed] [Google Scholar]
  34. Elovaara I., Poutiainen E., Raininko R., Valanne L., Virta A., Valle S. L., Lähdevirta J., Iivanainen M. Mild brain atrophy in early HIV infection: the lack of association with cognitive deficits and HIV-specific intrathecal immune response. J Neurol Sci. 1990 Nov;99(2-3):121–136. doi: 10.1016/0022-510x(90)90149-h. [DOI] [PubMed] [Google Scholar]
  35. Epstein L. G., Gendelman H. E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol. 1993 May;33(5):429–436. doi: 10.1002/ana.410330502. [DOI] [PubMed] [Google Scholar]
  36. Everall I., Luthert P., Lantos P. A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol. 1993 Nov;52(6):561–566. doi: 10.1097/00005072-199311000-00002. [DOI] [PubMed] [Google Scholar]
  37. Freeman R., Roberts M. S., Friedman L. S., Broadbridge C. Autonomic function and human immunodeficiency virus infection. Neurology. 1990 Apr;40(4):575–580. doi: 10.1212/wnl.40.4.575. [DOI] [PubMed] [Google Scholar]
  38. Fuller G. N., Jacobs J. M., Guiloff R. J. Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection. Lancet. 1989 Oct 21;2(8669):937–941. doi: 10.1016/s0140-6736(89)90952-5. [DOI] [PubMed] [Google Scholar]
  39. Fuller G. N., Jacobs J. M., Guiloff R. J. Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg Psychiatry. 1993 Apr;56(4):372–381. doi: 10.1136/jnnp.56.4.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gaines H., von Sydow M., Pehrson P. O., Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ. 1988 Nov 26;297(6660):1363–1368. doi: 10.1136/bmj.297.6660.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Geier S. A., Schielke E., Tatsch K., Sadri I., Bogner J. R., Hammel G., Einhäupl K. M., Goebel F. D. Brain HMPAO-SPECT and ocular microangiopathic syndrome in HIV-1-infected patients. AIDS. 1993 Dec;7(12):1589–1594. doi: 10.1097/00002030-199312000-00007. [DOI] [PubMed] [Google Scholar]
  42. Gelman B. B. Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann Neurol. 1993 Jul;34(1):65–70. doi: 10.1002/ana.410340112. [DOI] [PubMed] [Google Scholar]
  43. Gillespie S. M., Chang Y., Lemp G., Arthur R., Buchbinder S., Steimle A., Baumgartner J., Rando T., Neal D., Rutherford G. Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981-1989. Ann Neurol. 1991 Oct;30(4):597–604. doi: 10.1002/ana.410300413. [DOI] [PubMed] [Google Scholar]
  44. Girard P. M., Landman R., Gaudebout C., Olivares R., Saimot A. G., Jelazko P., Gaudebout C., Certain A., Boué F., Bouvet E. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group. N Engl J Med. 1993 May 27;328(21):1514–1520. doi: 10.1056/NEJM199305273282102. [DOI] [PubMed] [Google Scholar]
  45. Glass J. D., Wesselingh S. L., Selnes O. A., McArthur J. C. Clinical-neuropathologic correlation in HIV-associated dementia. Neurology. 1993 Nov;43(11):2230–2237. doi: 10.1212/wnl.43.11.2230. [DOI] [PubMed] [Google Scholar]
  46. Goldstein J. M., Azizi S. A., Booss J., Vollmer T. L. Human immunodeficiency virus-associated motor axonal polyradiculoneuropathy. Arch Neurol. 1993 Dec;50(12):1316–1319. doi: 10.1001/archneur.1993.00540120031009. [DOI] [PubMed] [Google Scholar]
  47. Grant I., Atkinson J. H., Hesselink J. R., Kennedy C. J., Richman D. D., Spector S. A., McCutchan J. A. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med. 1987 Dec;107(6):828–836. doi: 10.7326/0003-4819-107-6-828. [DOI] [PubMed] [Google Scholar]
  48. Grau J. M., Masanés F., Pedrol E., Casademont J., Fernández-Solá J., Urbano-Márquez A. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy. Ann Neurol. 1993 Aug;34(2):206–211. doi: 10.1002/ana.410340217. [DOI] [PubMed] [Google Scholar]
  49. Gray F., Geny C., Dournon E., Fenelon F., Lionnet F., Gherardi R. Neuropathological evidence that zidovudine reduces incidence of HIV infection of brain. Lancet. 1991 Apr 6;337(8745):852–853. doi: 10.1016/0140-6736(91)92560-o. [DOI] [PubMed] [Google Scholar]
  50. Gray F., Lescs M. C., Keohane C., Paraire F., Marc B., Durigon M., Gherardi R. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol. 1992 Mar;51(2):177–185. doi: 10.1097/00005072-199203000-00007. [DOI] [PubMed] [Google Scholar]
  51. Gulevich S. J., Kalmijn J. A., Thal L. J., Iragui-Madoz V., McCutchan J. A., Kennedy C., Grant I. Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group. Arch Neurol. 1992 Dec;49(12):1281–1284. doi: 10.1001/archneur.1992.00530360083022. [DOI] [PubMed] [Google Scholar]
  52. Hardy W. D., Feinberg J., Finkelstein D. M., Power M. E., He W., Kaczka C., Frame P. T., Holmes M., Waskin H., Fass R. J. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. N Engl J Med. 1992 Dec 24;327(26):1842–1848. doi: 10.1056/NEJM199212243272604. [DOI] [PubMed] [Google Scholar]
  53. Henson J., Rosenblum M., Armstrong D., Furneaux H. Amplification of JC virus DNA from brain and cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. Neurology. 1991 Dec;41(12):1967–1971. doi: 10.1212/wnl.41.12.1967. [DOI] [PubMed] [Google Scholar]
  54. Herzberg N. H., Zorn I., Zwart R., Portegies P., Bolhuis P. A. Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine. Muscle Nerve. 1992 Jun;15(6):706–710. doi: 10.1002/mus.880150613. [DOI] [PubMed] [Google Scholar]
  55. Hollander H., Levy J. A. Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid. Ann Intern Med. 1987 May;106(5):692–695. doi: 10.7326/0003-4819-106-5-692. [DOI] [PubMed] [Google Scholar]
  56. Hollander H., Stringari S. Human immunodeficiency virus-associated meningitis. Clinical course and correlations. Am J Med. 1987 Nov;83(5):813–816. doi: 10.1016/0002-9343(87)90635-8. [DOI] [PubMed] [Google Scholar]
  57. Hook E. W., 3rd, Marra C. M. Acquired syphilis in adults. N Engl J Med. 1992 Apr 16;326(16):1060–1069. doi: 10.1056/NEJM199204163261606. [DOI] [PubMed] [Google Scholar]
  58. Huang P. P., Chin R., Song S., Lasoff S. Lower motor neuron dysfunction associated with human immunodeficiency virus infection. Arch Neurol. 1993 Dec;50(12):1328–1330. doi: 10.1001/archneur.1993.00540120041011. [DOI] [PubMed] [Google Scholar]
  59. Illa I., Nath A., Dalakas M. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis. Ann Neurol. 1991 May;29(5):474–481. doi: 10.1002/ana.410290505. [DOI] [PubMed] [Google Scholar]
  60. Janssen R. S., Nwanyanwu O. C., Selik R. M., Stehr-Green J. K. Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology. 1992 Aug;42(8):1472–1476. doi: 10.1212/wnl.42.8.1472. [DOI] [PubMed] [Google Scholar]
  61. Johnston S. R., Corbett E. L., Foster O., Ash S., Cohen J. Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitis. J Infect. 1992 Mar;24(2):185–189. doi: 10.1016/0163-4453(92)92954-h. [DOI] [PubMed] [Google Scholar]
  62. Kamin S. S., Petito C. K. Idiopathic myelopathies with white matter vacuolation in non-acquired immunodeficiency syndrome patients. Hum Pathol. 1991 Aug;22(8):816–824. doi: 10.1016/0046-8177(91)90211-7. [DOI] [PubMed] [Google Scholar]
  63. Kaneko K., Onodera O., Miyatake T., Tsuji S. Rapid diagnosis of tuberculous meningitis by polymerase chain reaction (PCR). Neurology. 1990 Oct;40(10):1617–1618. doi: 10.1212/wnl.40.10.1617. [DOI] [PubMed] [Google Scholar]
  64. Karlsen N. R., Reinvang I., Frøland S. S. A follow-up study of neuropsychological function in asymptomatic HIV-infected patients. Acta Neurol Scand. 1993 Feb;87(2):83–87. doi: 10.1111/j.1600-0404.1993.tb04082.x. [DOI] [PubMed] [Google Scholar]
  65. Karlsen N. R., Reinvang I., Frøland S. S. Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand. 1992 Sep;86(3):242–246. doi: 10.1111/j.1600-0404.1992.tb05078.x. [DOI] [PubMed] [Google Scholar]
  66. Katz D. A., Berger J. R. Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol. 1989 Aug;46(8):895–898. doi: 10.1001/archneur.1989.00520440085024. [DOI] [PubMed] [Google Scholar]
  67. Kieburtz K. D., Giang D. W., Schiffer R. B., Vakil N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. Arch Neurol. 1991 Mar;48(3):312–314. doi: 10.1001/archneur.1991.00530150082023. [DOI] [PubMed] [Google Scholar]
  68. Koenig S., Gendelman H. E., Orenstein J. M., Dal Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. doi: 10.1126/science.3016903. [DOI] [PubMed] [Google Scholar]
  69. Kovacs J. A. Efficacy of atovaquone in treatment of toxoplasmosis in patients with AIDS. The NIAID-Clinical Center Intramural AIDS Program. Lancet. 1992 Sep 12;340(8820):637–638. doi: 10.1016/0140-6736(92)92172-c. [DOI] [PubMed] [Google Scholar]
  70. Lamperth L., Dalakas M. C., Dagani F., Anderson J., Ferrari R. Abnormal skeletal and cardiac muscle mitochondria induced by zidovudine (AZT) in human muscle in vitro and in an animal model. Lab Invest. 1991 Dec;65(6):742–751. [PubMed] [Google Scholar]
  71. Lane R. J., McLean K. A., Moss J., Woodrow D. F. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathol Appl Neurobiol. 1993 Oct;19(5):406–413. doi: 10.1111/j.1365-2990.1993.tb00462.x. [DOI] [PubMed] [Google Scholar]
  72. Lange D. J. AAEM minimonograph #41: neuromuscular diseases associated with HIV-1 infection. Muscle Nerve. 1994 Jan;17(1):16–30. doi: 10.1002/mus.880170104. [DOI] [PubMed] [Google Scholar]
  73. Lantos P. L., McLaughlin J. E., Schoitz C. L., Berry C. L., Tighe J. R. Neuropathology of the brain in HIV infection. Lancet. 1989 Feb 11;1(8633):309–311. doi: 10.1016/s0140-6736(89)91316-0. [DOI] [PubMed] [Google Scholar]
  74. Laskin O. L., Stahl-Bayliss C. M., Morgello S. Concomitant herpes simplex virus type 1 and cytomegalovirus ventriculoencephalitis in acquired immunodeficiency syndrome. Arch Neurol. 1987 Aug;44(8):843–847. doi: 10.1001/archneur.1987.00520200047017. [DOI] [PubMed] [Google Scholar]
  75. Levine A. M., Wernz J. C., Kaplan L., Rodman N., Cohen P., Metroka C., Bennett J. M., Rarick M. U., Walsh C., Kahn J. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial. JAMA. 1991 Jul 3;266(1):84–88. [PubMed] [Google Scholar]
  76. Levy J. A. HIV pathogenesis and long-term survival. AIDS. 1993 Nov;7(11):1401–1410. doi: 10.1097/00002030-199311000-00001. [DOI] [PubMed] [Google Scholar]
  77. Levy R. M., Russell E., Yungbluth M., Hidvegi D. F., Brody B. A., Dal Canto M. C. The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery. 1992 Feb;30(2):186–190. doi: 10.1227/00006123-199202000-00006. [DOI] [PubMed] [Google Scholar]
  78. Lewis W., Gonzalez B., Chomyn A., Papoian T. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. J Clin Invest. 1992 Apr;89(4):1354–1360. doi: 10.1172/JCI115722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Lidman C., Lindqvist L., Mathiesen T., Grane P. Progressive multifocal leukoencephalopathy in AIDS. AIDS. 1991 Aug;5(8):1039–1041. [PubMed] [Google Scholar]
  80. Lipton S. A. Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 1992 Mar;15(3):75–79. doi: 10.1016/0166-2236(92)90013-x. [DOI] [PubMed] [Google Scholar]
  81. MacMahon E. M., Glass J. D., Hayward S. D., Mann R. B., Becker P. S., Charache P., McArthur J. C., Ambinder R. F. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 1991 Oct 19;338(8773):969–973. doi: 10.1016/0140-6736(91)91837-k. [DOI] [PubMed] [Google Scholar]
  82. Manji H., Connolly S., McAllister R., Valentine A. R., Kendall B. E., Fell M., Durrance P., Thompson A. J., Newman S., Weller I. V. Serial MRI of the brain in asymptomatic patients infected with HIV: results from the UCMSM/Medical Research Council neurology cohort. J Neurol Neurosurg Psychiatry. 1994 Feb;57(2):144–149. doi: 10.1136/jnnp.57.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Mark A. S., Atlas S. W. Progressive multifocal leukoencephalopathy in patients with AIDS: appearance on MR images. Radiology. 1989 Nov;173(2):517–520. doi: 10.1148/radiology.173.2.2798883. [DOI] [PubMed] [Google Scholar]
  84. Marshall D. W., Brey R. L., Cahill W. T., Houk R. W., Zajac R. A., Boswell R. N. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol. 1988 Sep;45(9):954–958. doi: 10.1001/archneur.1988.00520330032007. [DOI] [PubMed] [Google Scholar]
  85. Masliah E., Ge N., Achim C. L., Hansen L. A., Wiley C. A. Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol. 1992 Nov;51(6):585–593. doi: 10.1097/00005072-199211000-00003. [DOI] [PubMed] [Google Scholar]
  86. McAllister R. H., Herns M. V., Harrison M. J., Newman S. P., Connolly S., Fowler C. J., Fell M., Durrance P., Manji H., Kendall B. E. Neurological and neuropsychological performance in HIV seropositive men without symptoms. J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):143–148. doi: 10.1136/jnnp.55.2.143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. McArthur J. C., Hoover D. R., Bacellar H., Miller E. N., Cohen B. A., Becker J. T., Graham N. M., McArthur J. H., Selnes O. A., Jacobson L. P. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology. 1993 Nov;43(11):2245–2252. doi: 10.1212/wnl.43.11.2245. [DOI] [PubMed] [Google Scholar]
  88. Menon D. K., Baudouin C. J., Tomlinson D., Hoyle C. Proton MR spectroscopy and imaging of the brain in AIDS: evidence of neuronal loss in regions that appear normal with imaging. J Comput Assist Tomogr. 1990 Nov-Dec;14(6):882–885. doi: 10.1097/00004728-199011000-00003. [DOI] [PubMed] [Google Scholar]
  89. Mhiri C., Baudrimont M., Bonne G., Geny C., Degoul F., Marsac C., Roullet E., Gherardi R. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol. 1991 Jun;29(6):606–614. doi: 10.1002/ana.410290607. [DOI] [PubMed] [Google Scholar]
  90. Miller E. N., Selnes O. A., McArthur J. C., Satz P., Becker J. T., Cohen B. A., Sheridan K., Machado A. M., Van Gorp W. G., Visscher B. Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology. 1990 Feb;40(2):197–203. doi: 10.1212/wnl.40.2.197. [DOI] [PubMed] [Google Scholar]
  91. Miller R. G., Storey J. R., Greco C. M. Ganciclovir in the treatment of progressive AIDS-related polyradiculopathy. Neurology. 1990 Apr;40(4):569–574. doi: 10.1212/wnl.40.4.569. [DOI] [PubMed] [Google Scholar]
  92. Moyle G. J., Nelson M. R., Hawkins D., Gazzard B. G. The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT) Q J Med. 1993 Mar;86(3):155–163. [PubMed] [Google Scholar]
  93. Narayan O., Clements J. E. Biology and pathogenesis of lentiviruses. J Gen Virol. 1989 Jul;70(Pt 7):1617–1639. doi: 10.1099/0022-1317-70-7-1617. [DOI] [PubMed] [Google Scholar]
  94. Navia B. A., Jordan B. D., Price R. W. The AIDS dementia complex: I. Clinical features. Ann Neurol. 1986 Jun;19(6):517–524. doi: 10.1002/ana.410190602. [DOI] [PubMed] [Google Scholar]
  95. Pagano M. A., Cahn P. E., Garau M. L., Mangone C. A., Figini H. A., Yorio A. A., Dellepiane M. C., Amores M. G., Perez H. M., Casiró A. D. Brain-stem auditory evoked potentials in human immunodeficiency virus-seropositive patients with and without acquired immunodeficiency syndrome. Arch Neurol. 1992 Feb;49(2):166–169. doi: 10.1001/archneur.1992.00530260068022. [DOI] [PubMed] [Google Scholar]
  96. Peters B. S., Winer J., Landon D. N., Stotter A., Pinching A. J. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS. Q J Med. 1993 Jan;86(1):5–15. [PubMed] [Google Scholar]
  97. Petito C. K., Cash K. S. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol. 1992 Nov;32(5):658–666. doi: 10.1002/ana.410320509. [DOI] [PubMed] [Google Scholar]
  98. Petito C. K., Navia B. A., Cho E. S., Jordan B. D., George D. C., Price R. W. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1985 Apr 4;312(14):874–879. doi: 10.1056/NEJM198504043121402. [DOI] [PubMed] [Google Scholar]
  99. Petty R. K., Kennedy P. G. The neurological features of HIV-positive patients in Glasgow--a retrospective study of 90 cases. Q J Med. 1992 Mar;82(299):223–234. [PubMed] [Google Scholar]
  100. Peudenier S., Hery C., Montagnier L., Tardieu M. Human microglial cells: characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV-1 infection. Ann Neurol. 1991 Feb;29(2):152–161. doi: 10.1002/ana.410290207. [DOI] [PubMed] [Google Scholar]
  101. Pezeshkpour G., Illa I., Dalakas M. C. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Hum Pathol. 1991 Dec;22(12):1281–1288. doi: 10.1016/0046-8177(91)90112-3. [DOI] [PubMed] [Google Scholar]
  102. Portegies P., Enting R. H., de Gans J., Algra P. R., Derix M. M., Lange J. M., Goudsmit J. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands. AIDS. 1993 May;7(5):669–675. [PubMed] [Google Scholar]
  103. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992 Dec 3;327(23):1643–1648. doi: 10.1056/NEJM199212033272306. [DOI] [PubMed] [Google Scholar]
  104. Poutiainen E., Elovaara I., Raininko R., Hokkanen L., Valle S. L., Lähdevirta J., Iivanainen M. Cognitive performance in HIV-1 infection: relationship to severity of disease and brain atrophy. Acta Neurol Scand. 1993 Feb;87(2):88–94. doi: 10.1111/j.1600-0404.1993.tb04083.x. [DOI] [PubMed] [Google Scholar]
  105. Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793–798. doi: 10.1056/NEJM199203193261203. [DOI] [PubMed] [Google Scholar]
  106. Power C., Kong P. A., Crawford T. O., Wesselingh S., Glass J. D., McArthur J. C., Trapp B. D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol. 1993 Sep;34(3):339–350. doi: 10.1002/ana.410340307. [DOI] [PubMed] [Google Scholar]
  107. Price R. W., Brew B. J. The AIDS dementia complex. J Infect Dis. 1988 Nov;158(5):1079–1083. doi: 10.1093/infdis/158.5.1079. [DOI] [PubMed] [Google Scholar]
  108. Ragazzoni A., Grippo A., Ghidini P., Schiavone V., Lolli F., Mazzotta F., Mecocci L., Pinto F. Electrophysiological study of neurologically asymptomatic HIV1 seropositive patients. Acta Neurol Scand. 1993 Jan;87(1):47–51. doi: 10.1111/j.1600-0404.1993.tb04074.x. [DOI] [PubMed] [Google Scholar]
  109. Rance N. E., McArthur J. C., Cornblath D. R., Landstrom D. L., Griffin J. W., Price D. L. Gracile tract degeneration in patients with sensory neuropathy and AIDS. Neurology. 1988 Feb;38(2):265–271. doi: 10.1212/wnl.38.2.265. [DOI] [PubMed] [Google Scholar]
  110. Reinvang I., Frøland S. S., Skripeland V. Prevalence of neuropsychological deficit in HIV infection. Incipient signs of AIDS dementia complex in patients with AIDS. Acta Neurol Scand. 1991 May;83(5):289–293. doi: 10.1111/j.1600-0404.1991.tb04703.x. [DOI] [PubMed] [Google Scholar]
  111. Remick S. C., Diamond C., Migliozzi J. A., Solis O., Wagner H., Jr, Haase R. F., Ruckdeschel J. C. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature. Medicine (Baltimore) 1990 Nov;69(6):345–360. doi: 10.1097/00005792-199011000-00003. [DOI] [PubMed] [Google Scholar]
  112. Reyes M. G., Faraldi F., Senseng C. S., Flowers C., Fariello R. Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 1991;82(1):39–44. doi: 10.1007/BF00310921. [DOI] [PubMed] [Google Scholar]
  113. Rosci M. A., Pigorini F., Bernabei A., Pau F. M., Volpini V., Merigliano D. E., Meligrana M. F. Methods for detecting early signs of AIDS dementia complex in asymptomatic HIV-1-infected subjects. AIDS. 1992 Nov;6(11):1309–1316. doi: 10.1097/00002030-199211000-00011. [DOI] [PubMed] [Google Scholar]
  114. Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83–89. doi: 10.1056/NEJM199201093260202. [DOI] [PubMed] [Google Scholar]
  115. Said G., Lacroix C., Chemouilli P., Goulon-Goeau C., Roullet E., Penaud D., de Broucker T., Meduri G., Vincent D., Torchet M. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol. 1991 Feb;29(2):139–146. doi: 10.1002/ana.410290205. [DOI] [PubMed] [Google Scholar]
  116. Scaravilli F., Sinclair E., Arango J. C., Manji H., Lucas S., Harrison M. J. The pathology of the posterior root ganglia in AIDS and its relationship to the pallor of the gracile tract. Acta Neuropathol. 1992;84(2):163–170. doi: 10.1007/BF00311390. [DOI] [PubMed] [Google Scholar]
  117. Selnes O. A., McArthur J. C., Royal W., 3rd, Updike M. L., Nance-Sproson T., Concha M., Gordon B., Solomon L., Vlahov D. HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology. 1992 Oct;42(10):1924–1930. doi: 10.1212/wnl.42.10.1924. [DOI] [PubMed] [Google Scholar]
  118. Sharer L. R., Dowling P. C., Michaels J., Cook S. D., Menonna J., Blumberg B. M., Epstein L. G. Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol. 1990 Aug;16(4):317–331. doi: 10.1111/j.1365-2990.1990.tb01266.x. [DOI] [PubMed] [Google Scholar]
  119. Sidtis J. J., Gatsonis C., Price R. W., Singer E. J., Collier A. C., Richman D. D., Hirsch M. S., Schaerf F. W., Fischl M. A., Kieburtz K. Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group. Ann Neurol. 1993 Apr;33(4):343–349. doi: 10.1002/ana.410330403. [DOI] [PubMed] [Google Scholar]
  120. Simpson D. M., Bender A. N. Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol. 1988 Jul;24(1):79–84. doi: 10.1002/ana.410240114. [DOI] [PubMed] [Google Scholar]
  121. Sinicco A., Fora R., Sciandra M., Lucchini A., Caramello P., Gioannini P. Risk of developing AIDS after primary acute HIV-1 infection. J Acquir Immune Defic Syndr. 1993 Jun;6(6):575–581. [PubMed] [Google Scholar]
  122. Skolnik P. R., Kosloff B. R., Hirsch M. S. Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J Infect Dis. 1988 Mar;157(3):508–514. doi: 10.1093/infdis/157.3.508. [DOI] [PubMed] [Google Scholar]
  123. Snider W. D., Simpson D. M., Nielsen S., Gold J. W., Metroka C. E., Posner J. B. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983 Oct;14(4):403–418. doi: 10.1002/ana.410140404. [DOI] [PubMed] [Google Scholar]
  124. So Y. T., Beckstead J. H., Davis R. L. Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study. Ann Neurol. 1986 Nov;20(5):566–572. doi: 10.1002/ana.410200503. [DOI] [PubMed] [Google Scholar]
  125. So Y. T., Holtzman D. M., Abrams D. I., Olney R. K. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey. Arch Neurol. 1988 Sep;45(9):945–948. doi: 10.1001/archneur.1988.00520330023005. [DOI] [PubMed] [Google Scholar]
  126. Tada H., Rappaport J., Lashgari M., Amini S., Wong-Staal F., Khalili K. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc Natl Acad Sci U S A. 1990 May;87(9):3479–3483. doi: 10.1073/pnas.87.9.3479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Tan S. V., Guiloff R. J., Scaravilli F., Klapper P. E., Cleator G. M., Gazzard B. G. Herpes simplex type 1 encephalitis in acquired immunodeficiency syndrome. Ann Neurol. 1993 Oct;34(4):619–622. doi: 10.1002/ana.410340418. [DOI] [PubMed] [Google Scholar]
  128. Till M., MacDonell K. B. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine? Ann Intern Med. 1990 Oct 1;113(7):492–494. doi: 10.7326/0003-4819-113-7-492. [DOI] [PubMed] [Google Scholar]
  129. Vago L., Castagna A., Lazzarin A., Trabattoni G., Cinque P., Costanzi G. Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine. J Acquir Immune Defic Syndr. 1993 Jan;6(1):42–45. [PubMed] [Google Scholar]
  130. Verhofstede C., Reniers S., Colebunders R., van Wanzeele F., Plum J. Polymerase chain reaction in the diagnosis of Toxoplasma encephalitis. AIDS. 1993 Nov;7(11):1539–1541. [PubMed] [Google Scholar]
  131. Wheat L. J., Batteiger B. E., Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore) 1990 Jul;69(4):244–260. doi: 10.1097/00005792-199007000-00006. [DOI] [PubMed] [Google Scholar]
  132. Wijdicks E. F., Borleffs J. C., Hoepelman A. I., Jansen G. H. Fatal disseminated hemorrhagic toxoplasmic encephalitis as the initial manifestation of AIDS. Ann Neurol. 1991 Jun;29(6):683–686. doi: 10.1002/ana.410290620. [DOI] [PubMed] [Google Scholar]
  133. Wiley C. A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann Neurol. 1991 Jun;29(6):651–657. doi: 10.1002/ana.410290613. [DOI] [PubMed] [Google Scholar]
  134. Wiley C. A., Schrier R. D., Nelson J. A., Lampert P. W., Oldstone M. B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7089–7093. doi: 10.1073/pnas.83.18.7089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Wilkie F. L., Morgan R., Fletcher M. A., Blaney N., Baum M., Komaroff E., Szapocznik J., Eisdorfer C. Cognition and immune function in HIV-1 infection. AIDS. 1992 Sep;6(9):977–981. doi: 10.1097/00002030-199209000-00011. [DOI] [PubMed] [Google Scholar]
  136. Winer J. B., Bang B., Clarke J. R., Knox K., Cook T. J., Gompels M., Hughes R. A., Hall S. M., Pinching A. J., Harris J. W. A study of neuropathy in HIV infection. Q J Med. 1992 Jun;83(302):473–488. [PubMed] [Google Scholar]
  137. Zimmer C., Märzheuser S., Patt S., Rolfs A., Gottschalk J., Weigel K., Gosztonyi G. Stereotactic brain biopsy in AIDS. J Neurol. 1992 Aug;239(7):394–400. doi: 10.1007/BF00812158. [DOI] [PubMed] [Google Scholar]
  138. de Gans J., Portegies P., Tiessens G., Eeftinck Schattenkerk J. K., van Boxtel C. J., van Ketel R. J., Stam J. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis. AIDS. 1992 Feb;6(2):185–190. doi: 10.1097/00002030-199202000-00007. [DOI] [PubMed] [Google Scholar]
  139. de la Monte S. M., Gabuzda D. H., Ho D. D., Brown R. H., Jr, Hedley-Whyte E. T., Schooley R. T., Hirsch M. S., Bhan A. K. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol. 1988 May;23(5):485–492. doi: 10.1002/ana.410230510. [DOI] [PubMed] [Google Scholar]
  140. del Rio C., Soffer O., Widell J. L., Judd R. L., Slade B. A. Acute human immunodeficiency virus infection temporally associated with rhabdomyolysis, acute renal failure, and nephrosis. Rev Infect Dis. 1990 Mar-Apr;12(2):282–285. doi: 10.1093/clinids/12.2.282. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES